Derivatisation of buforin IIb, a cationic henicosapeptide, to afford its complexation to platinum( ii ) resulting in a novel platinum( ii )–buforin IIb conjugate with anti-cancer activity
- 13 June 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (33) , 13038-13041
Abstract
Herein we report the synthesis and anti-cancer activity of buforin IIb, its novel malonate derivative malBuf and its Pt( ii ) complex cis -[Pt(NH 3 ) 2 (malBuf –2H )].Keywords
Funding Information
- Science Foundation Ireland ([06/RFP/CHO024/602 EC07])
- Science Foundation Ireland ([08/RFPCHE1675])
- Science Foundation Ireland ([11/RFP.1/CHS/3095])
This publication has 13 references indexed in Scilit:
- Inspiration from the mirror: D-amino acid containing peptides in biomedical approachesBioMolecular Concepts, 2016
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsChemical Reviews, 2016
- Buforin IIb induces endoplasmic reticulum stress-mediated apoptosis in HeLa cellsPeptides, 2015
- Targeting Mitochondrial DNA with a Platinum-Based Anticancer AgentChemistry & Biology, 2013
- Derivatisation of an Anti‐Cancer Cationic Antimicrobial Peptide and its Complexation to Platinum(II)Zeitschrift für anorganische und allgemeine Chemie, 2013
- Enhancement of the cancer targeting specificity of buforin IIb by fusion with an anionic peptide via a matrix metalloproteinases-cleavable linkerPeptides, 2011
- Peptide Targeting of Platinum Anti-Cancer DrugsBioconjugate Chemistry, 2009
- Solid-phase synthesis and DNA binding studies of dichloroplatinum(ii) conjugates of dicarba analogues of octreotide as new anticancer drugsChemical Communications, 2009
- Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptideCancer Letters, 2008
- The First Solid-Phase Synthesis of a Peptide-Tethered Platinum(II) Complex2000